Leonardo Dionisio

Leonardo Dionisio


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in Neuropharmacology
Verified
Journal Article
Closed access
LDLeonardo Dionisio
Leonardo Dionisio
MRMaria Jose De Rosa
Maria Jose De Rosa
CBCecilia Bouzat
Cecilia Bouzat
MEMaría del Carmen Esandi
María del Carmen Esandi

1 September 2009 in Life Sciences
Verified
Journal Article
Closed access
MRMaria Jose De Rosa
Maria Jose De Rosa
LDLeonardo Dionisio
Leonardo Dionisio
EAEvangelina Agriello
Evangelina Agriello
CBCecilia Bouzat
Cecilia Bouzat
MEMaría del Carmen Esandi
María del Carmen Esandi

1 July 2019 in Neuroscience
Verified
Journal Article
Closed access
CCCamila Carignano
Camila Carignano
EBEsteban Pablo Barila
Esteban Pablo Barila
EREzequiel Ignacio Rías
Ezequiel Ignacio Rías
LDLeonardo Dionisio
Leonardo Dionisio
EAEugenio Aztiria
Eugenio Aztiria
GSGuillermo Spitzmaul
Guillermo Spitzmaul

1 December 2013 in Biochimie
Verified
Journal Article
Closed access
LDLeonardo Dionisio
Leonardo Dionisio
VAVerónica Arias
Verónica Arias
CBCecilia Bouzat
Cecilia Bouzat
MEMaría del Carmen Esandi
María del Carmen Esandi

3 June 2014 in Neuroscience
Verified
Journal Article
Closed access
CBCarlos Javier Baier
Carlos Javier Baier
DFD.L. Franco
D.L. Franco
CGC.E. Gallegos
C.E. Gallegos
LMLucas A Mongiat
Lucas A Mongiat
LDLeonardo Dionisio
Leonardo Dionisio
FBFrancisco J. Barrantes
Francisco J. Barrantes

1 March 2015 in Molecular Pharmacology
Verified
Journal Article
Open access
PDF file
LDLeonardo Dionisio
Leonardo Dionisio
IBIgnacio Bergé
Ignacio Bergé
MBMatías Bravo
Matías Bravo
MEMaría del Carmen Esandi
María del Carmen Esandi
CBCecilia Bouzat
Cecilia Bouzat
Cys-loop receptors are neurotransmitter-activated ion channels involved in synaptic and extrasynaptic transmission in the brain and are also present in non-neuronal cells. As GABAA and nicotinic receptors (nAChR) belong to this family, we explored by macroscopic and single-channel recordings whether the inhibitory neurotransmitter GABA has the ability to activate excitatory nAChRs. GABA differentially activates nAChR subtypes. It activates muscle nAChRs, with maximal peak currents of about 10% of those elicited by acetylcholine (ACh) and 15-fold higher EC50 with respect to ACh. At the single-channel level, the weak agonism is revealed by the requirement of 20-fold higher concentration of GABA for detectable channel openings, a major population of brief openings, and absence of clusters of openings when compared with ACh. Mutations at key residues of the principal binding-site face of muscle nAChRs (αY190 and αG153) affect GABA activation similarly as ACh activation, whereas a mutation at the complementary face (εG57) shows a selective effect for GABA. Studies with subunit-lacking receptors show that GABA can activate muscle nAChRs through the α/δ interface. Interestingly, single-channel activity elicited by GABA is similar to that elicited by ACh in gain-of-function nAChR mutants associated to congenital myasthenic syndromes, which could be important in the progression of the disorders due to steady exposure to serum GABA. In contrast, GABA cannot elicit single-channel or macroscopic currents of α7 or the chimeric α7-serotonin-type 3 receptor, a feature important for preserving an adequate excitatory/inhibitory balance in the brain as well as for avoiding activation of non-neuronal receptors by serum GABA.